Search results
1 company and 4 research reports found for "Medivir"
Company results
- Medivir
Medivir is a Swedish biotech company focused on infectious diseases (primarily hepatitis C). The inv...
Sector reports
No sector reports have been found.
Research results
Medivir
First DAA combo study
QuickView | Pharmaceutical & Healthcare | 12/12/2011The recent collaboration that allows J&J to evaluate TMC435 in combination with daclatasvir, an investigational anti-HCV compound from BMS, represents...
Medivir
Interesting opportunity
QuickView | Pharmaceutical & Healthcare | 24/11/2011Medivir’s presence in the chronic hepatitis C space seems to have been overlooked by the market in the week Gilead acquired rival Pharmasset for...
Medivir
An integrated business
QuickView | Pharmaceutical & Healthcare | 18/04/2011In a clever move to build a Nordic sales operation, Medivir has offered SEK565m in cash and equity to acquire BioPhausia, a Stockholm-listed, Nordic a...
Medivir
Four horse race
QuickView | Pharmaceutical & Healthcare | 23/02/2011Medivir’s partner Tibotec, a unit of J&J, has moved TMC435 into Phase III studies for chronic hepatitis C. TMC435 has shown strong efficacy and coul...
